AAAAAA
Results: 1-25/1363
Authors:
Perret, J
Delattre, JY
Citation: J. Perret et Jy. Delattre, Consensus Conference organised by the French Federation for Neurology - Multiple sclerosis - Piti -Salp tri re Hospital, Amphith atre Charcot, 7 and 8 June 2001 - Foreword, REV NEUROL, 157(8-9), 2001, pp. 902-902
Authors:
Lyon-Caen, O
Citation: O. Lyon-caen, Consensus Conference on Multiple Sclerosis, REV NEUROL, 157(8-9), 2001, pp. 903-903
Authors:
Confavreux, C
Vukusic, S
Achiti, J
Citation: C. Confavreux et al., Diagnostic criteria according to the different clinical forms, REV NEUROL, 157(8-9), 2001, pp. 907-913
Authors:
Dimitri, D
Citation: D. Dimitri, Diagnostic criteria and definition of the clinical course of multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 914-928
Authors:
Fontaine, B
Citation: B. Fontaine, Borderline forms of multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 929-934
Authors:
Dupel-Pottier, C
Citation: C. Dupel-pottier, Diagnosis criteria of borderline forms of multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 935-943
Authors:
Berry, I
Citation: I. Berry, Diagnosis criteria of multiple sclerosis: neuroimaging criteria, REV NEUROL, 157(8-9), 2001, pp. 944-948
Authors:
Dupel-Pottier, C
Citation: C. Dupel-pottier, Diagnosis criteria of multiple sclerosis in neuroimaging, REV NEUROL, 157(8-9), 2001, pp. 949-962
Authors:
Liblau, R
Citation: R. Liblau, Contribution of laboratory tests to the diagnosis of multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 963-967
Authors:
Dimitri, D
Citation: D. Dimitri, Biologic diagnostic criteria of multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 968-973
Authors:
Fischer, C
Andre-Obadia, N
Mauguiere, F
Citation: C. Fischer et al., Diagnostic criteria of multiple sclerosis: electrophysiological criteria, REV NEUROL, 157(8-9), 2001, pp. 974-980
Authors:
Dimitri, D
Citation: D. Dimitri, Electrophysiological diagnostic criteria of multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 981-986
Authors:
Brochet, B
Citation: B. Brochet, Therapeutic indications during acute episodes of multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 988-995
Authors:
Lubetzki, C
Citation: C. Lubetzki, Treatment of relapsing remitting multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 996-1000
Authors:
Rumbach, L
Citation: L. Rumbach, Indications for etiological treatment in progressive multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 1001-1007
Authors:
Edan, G
Citation: G. Edan, Treatment of rapidly worsening multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 1008-1013
Authors:
Brassat, D
Citation: D. Brassat, Indications for etiological treatment (excepting primary progressive MS), REV NEUROL, 157(8-9), 2001, pp. 1014-1028
Physiotherapy of motor disorders in multiple sclerosis patients: critical overview of the literature
Authors:
Pelissier, J
Benaim, C
Petiot, S
Citation: J. Pelissier et al., Physiotherapy of motor disorders in multiple sclerosis patients: critical overview of the literature, REV NEUROL, 157(8-9), 2001, pp. 1030-1040
Authors:
Bussel, B
Neris, OR
Mailhan, L
Citation: B. Bussel et al., Spasticity in multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 1041-1044
Authors:
Lebrun, C
Citation: C. Lebrun, Indications for symptomatic treatment of spasticity in multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 1045-1050
Authors:
Joseph, PA
de Seze, M
Citation: Pa. Joseph et M. De Seze, Sphincter and bladder dysfonction, REV NEUROL, 157(8-9), 2001, pp. 1051-1059
Authors:
Lebrun, C
Citation: C. Lebrun, Therapeutic indications for symptomatic treatment of bladder and bowel disorders in multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 1060-1065
Authors:
Waubant, E
Citation: E. Waubant, Indications for symptomatic treatment: fatigue, REV NEUROL, 157(8-9), 2001, pp. 1066-1071
Authors:
Chatel, M
Lanteri-Minet, M
Lebrun-Frenay, C
Citation: M. Chatel et al., Pain in multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 1072-1078
Authors:
Viallet, F
Witjas, T
Gayraud, D
Pelletier, J
Regis, J
Citation: F. Viallet et al., Tremor and movement disorders in multiple sclerosis: indications for symptomatic treatment, REV NEUROL, 157(8-9), 2001, pp. 1079-1084